From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

CDC distribution roadmap, safety oversight plans, and other takeaways from FDA’s big COVID-19 vaccine meeting - ExBulletin

In less than a year, scientists around the world have rallied against COVID-19 and developed promising vaccines that could stem the pandemic.

Group Of Independent Experts To Advise FDA On Coronavirus Vaccine Approval - WUWM Milwaukee

It's up to the Food and Drug Administration to decide whether a COVID-19 vaccine is safe and effective enough for public distribution.

FOUR TAKEAWAYS FROM THE FIRST COVID ADCOMM - POLITICO Prescription Pulse

The much-anticipated, nine-hour initial public meeting of FDA’s advisory committee on vaccines broached diversity in clinical trials, when placebo patients should get the real thing and how to counteract sinking public con

In historic Covid-19 adcomm, vaccine experts debate a sea of questions — but offer no clear answers - Endpoints News

The most widely anticipated and perhaps most widely watched meeting in the FDA’s 113-year history ended late Thursday night with a score of questions and very few answers.

Confidence still lacking in future COVID-19 vaccines - BioWorld

With the lack of public trust and confidence the biggest barrier to SARS-CoV-2 vaccines in the U.S., the risk of granting an emergency use authorization (EUA) to a vaccine with safety issues or questionable efficacy could

Core Concept: The pandemic is prompting widespread use—and misuse—of real-world data - PNAS

COVID-19 has swept across the world, overwhelming healthcare systems and raising countless questions about how best to diagnose patients, treat infections, save lives, and contain the pandemic.

FDA study finds fear and distrust among front-line workers and minority groups around COVID-19 vaccines - Fierce Pharma

Powerful, illuminating and sobering—that’s the description from a research group summing up its initial listening sessions with front-line workers and minority groups about a vaccine.

What to expect from the official COVID-19 vaccine committee - ABC News

As the race for an effective COVID-19 vaccine continues, the public will get inside look at one a crucial part of the Food and Drug Administration's decisio

October, no surprise: COVID-19 vax AdComm booked for the 22nd - RAPS

The US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee plans to meet on 22 October to discuss matters related to authorization and licensure of vaccines for COVID-19.

FDA Applauds Role of Clinical Trials in Fighting COVID-19 - The Association of Clinical Research Professionals

“Clinical trials are critical” in the battle against the global COVID-19 pandemic, Amy Abernathy, principal deputy commissioner and acting CIO of the U.S.